For the Inventor, By the Inventor

Enter assignee name

Laboratoires Upsa

USPTO Granted Patents = 22

Forward Citations = 358

Loading Chart...

Loading Chart...

19 inventors (with patents filed for the assignee):

Jean-Marie C Teulon (18 out of 40 patents)

Nicole Bru-Magniez (17 out of 28 patents)

Eric Nicolai (7 out of 18 patents)

4. Timur Gungor (6 out of 9 patents)

5. Michele Launay (5 out of 14 patents)

6. Dominique Potin (2 out of 11 patents)

7. Christian De Cock (2 out of 2 patents)

8. Jean-Luc De Keyser (2 out of 2 patents)

9. Jean-Francois S Cordoliani (2 out of 2 patents)

10. Jehan-Yves P Drouin (2 out of 3 patents)

11. Jacques H Poupaert (2 out of 4 patents)

12. Pierre A Dumont (2 out of 4 patents)

13. Alix Cloarec (1 out of 1 patent)

14. Francoise Camborde (1 out of 1 patent)

15. Eric Sartori (1 out of 3 patents)

22 patents: Sort by Forward Citations

1. 6015797 - Adenosinergic agonist containing pharmaceutical composition with (2000-01-18),

2. 6004994 - Heterocyclic diarylmethylene derivatives, methods of preparing them and (1999-12-21),

3. 5686460 - Carbocyclic diarylmethylene derivatives, processes for their preparation (1997-11-11),

4. 5663181 - Naphthyridine derivatives, their methods of preparation and (1997-09-02),

5. 5480983 - Adenosine derivatives, preparation methods and pharmaceutical (1996-01-02),

6. 5480652 - Effervescent pharmaceutical composition containing ibuprofen and its (1996-01-02),

7. 5459132 - N6-[(Imidazo[1,2-a]pyridin-3-yl)ethyl]adenosines, their 5'-uronamide (1995-10-17),

8. 5437874 - Pharmaceutical composition for the preparation of a stable powder (1995-08-01),

9. 5418242 - Piperidinylthioindole derivatives, their methods of preparation and (1995-05-23),

10. 5389632 - Pyrazolopyrimidine derivatives which are angiotensin II receptor (1995-02-14),

11. 5387747 - Triazolopyrimidine derivatives which are angiotensin II receptor (1995-02-07),

12. 5364860 - Naphthyridine compounds which inhibit tyrosine kinase and their (1994-11-15),

13. 5358950 - Triazolopyrimidine derivatives which are angiotensin II receptor (1994-10-25),

14. 5229505 - N.sup.6 -[3-(1-substituted)indolylethyl] adenosine 5'-carboxamides and (1993-07-20),

15. 5217973 - Triazolopyrimidine derivatives which are angiotensin II receptor (1993-06-08),

Laboratoires Upsa, based in Agen, France, specializes in the development and manufacturing of pharmaceutical products, particularly in the fields of pain relief and cold treatments. The company is committed to innovation in healthcare, focusing on creating effective and accessible medications. With a strong emphasis on research and development, Laboratoires Upsa aims to enhance patient well-being through its diverse range of over-the-counter products, catering to both local and international markets.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

22 Patents

#1 in Agen

#936 in France

#28,724 in the World

Laboratoires Upsa

Forward Citations = 358

19 inventors:

Jean-Marie C Teulon (18 out of 40 patents)

Nicole Bru-Magniez (17 out of 28 patents)

Eric Nicolai (7 out of 18 patents)

4. Timur Gungor (6 out of 9 patents)

5. Michele Launay (5 out of 14 patents)

Please report any incorrect information to [email protected]

Loading…